Osaic Holdings’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
Other funds holding CUE
BL
GWMR
VCM
LPC
VFT
RSWM
TCBWMS
AWM
Osaic Holdings's CUE Position: Q1 2026 in Review
Osaic Holdings reduced its Cue Biopharma (CUE) stake by 57% in Q1 2026, selling an estimated $121 and leaving 10 shares worth $69. The position accounts for ﹤0.01% of the portfolio, ranked #7658.
Osaic Holdings first reported a position in CUE in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.41M in Q1 2022. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.
- Osaic Holdings held 10 shares of Cue Biopharma worth $69 as of Q1 2026.
- Osaic Holdings sold 13 Cue Biopharma shares in Q1 2026, an estimated $121.
- Cue Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7658 holding.
- Osaic Holdings first reported a position in Cue Biopharma in Q1 2020 and has held it in 25 quarters since.
- Osaic Holdings's Cue Biopharma position peaked at $2.41M in Q1 2022.
- 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.